InVivo Therapeutics Corp Ratio court
Quel est le Ratio court de InVivo Therapeutics Corp?
Le Ratio court de InVivo Therapeutics Holdings Corp est 0.09
Quelle est la définition de Ratio court?
Le ratio court des actions vendues est le nombre d'actions vendues à découvert divisé par le volume quotidien moyen.
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Ratio court des entreprises dans Health Care secteur sur NASDAQ par rapport à InVivo Therapeutics Corp
Que fait InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Entreprises avec ratio court similaire à InVivo Therapeutics Corp
- Wittering Capital Corp a Ratio court de 0.08
- Dragoneer Growth Opportunities II a Ratio court de 0.08
- Triumph a Ratio court de 0.08
- Goldeneye Resources a Ratio court de 0.08
- Trilogy International Partners a Ratio court de 0.08
- Western Asset Variable Rate Strategic Fund a Ratio court de 0.08
- InVivo Therapeutics Corp a Ratio court de 0.09
- Stallion Gold Corp a Ratio court de 0.10
- Insurance Acquisition a Ratio court de 0.10
- Whatcom Capital a Ratio court de 0.10
- PLB Capital a Ratio court de 0.10
- Freeform Capital Partners a Ratio court de 0.10
- Axis Auto Finance a Ratio court de 0.10